News in brief: Epsilon launches biotech arm; LGP sells WA facility for $7.8m; Neurotech partners with University of Sydney on Rett program by Adam Sheldon February 18, 2026February 19, 2026 Epsilon Healthcare has established a new subsidiary, Epsilon Biotech, which the firm said would accelerate its […]
News in brief: ASX questions Neurotech over funding; participants sought for endometriosis trial in Sydney by Adam Sheldon October 29, 2025February 21, 2026
Financial news in brief: Elixinol reassures ASX over financing; NTI shuts down two subsidiaries by Steve Jones August 1, 2025August 1, 2025
Dr Bonni Goldstein joins Neurotech push to register cannabis drug for paediatric patients by Steve Jones June 16, 2025June 16, 2025
PK study shows further promise for Neurotech paediatric CBDA drug by Steve Jones June 3, 2025June 3, 2025
US FDA rejects Neurotech application for orphan drug status by Steve Jones October 8, 2024February 25, 2025
Neurotech seeks pharma partners for overseas drug development but will go it alone in Australia by Steve Jones August 12, 2024August 12, 2024
Cannabinoid drug developer holds ‘positive’ talks with TGA as hopes rise of fast-tracking ARTG listing by Steve Jones June 28, 2024June 28, 2024
Neurotech reports strong trial results as firm raises A$10m to fund drug-registration activities by Steve Jones April 17, 2024April 18, 2024
Company news: Zelira; ECS Botanics; LGP; Ecofibre; Neurotech; Elixinol; Emyria by Steve Jones and Martin Lane February 28, 2024July 16, 2024
